Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
about
A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent mannerKIT Mutations and CD117 Overexpression Are Markers of Better Progression-Free Survival in Vulvar Melanomas.Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.Identification of recurrent mutational events in anorectal melanoma.Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
P2860
Q28817145-21D8F556-B703-4523-809F-7DAD1892391BQ38372948-F52C64C1-3BD0-4749-967D-A7BF5AB6CA93Q38870985-FF18D14C-292D-40DE-9FA2-64D5C99A67EBQ50068807-5B6F9243-980A-4417-B4CC-FF303C3FF49BQ51746622-8C21FB3B-0057-4FEA-8171-2822A262400EQ53009744-A4198C35-4CD6-48A4-9D0F-0CEC4E7A488EQ55421307-1A71D329-38C5-41AE-85E6-6BA61C3FB355
P2860
Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
@en
type
label
Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
@en
prefLabel
Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
@en
P2093
P2860
P1476
Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
@en
P2093
Douglas B Johnson
Jeffrey A Sosman
Romany A N Johnpulle
P2860
P2888
P356
10.1007/S11912-015-0485-6
P577
2016-01-01T00:00:00Z
P6179
1012982146